ClearBridge Investments
PVLA icon

ClearBridge Investments’s Palvella Therapeutics PVLA Stock Holding History

ClearBridge Investments’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.07M Sell
59,341
-69
-0.1% -$8.38K 0.01% 512
2026
Q1 		$7.41M Sell
59,410
-1,218
-2% -$127K 0.01% 506
2025
Q4 		$6.35M Buy
+60,628
New +$5.17M 0.01% 552

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

ClearBridge Investments's PVLA Position: Q2 2026 in Review

ClearBridge Investments reduced its Palvella Therapeutics (PVLA) stake by 0.12% in Q2 2026, selling an estimated $8.38K and leaving 59,341 shares worth $9.07M. The position accounts for 0.01% of the portfolio, ranked #512.

ClearBridge Investments first reported a position in PVLA in Q4 2025 and has held it in 3 quarters since. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • ClearBridge Investments held 59,341 shares of Palvella Therapeutics worth $9.07M as of Q2 2026.
  • ClearBridge Investments sold 69 Palvella Therapeutics shares in Q2 2026, an estimated $8.38K.
  • Palvella Therapeutics made up 0.01% of ClearBridge Investments's portfolio in Q2 2026, its #512 holding.
  • ClearBridge Investments first reported a position in Palvella Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.